Atrial fibrillation and stroke prevention

@article{Lip2007AtrialFA,
  title={Atrial fibrillation and stroke prevention},
  author={Gregory Y H Lip and Hoong Sern Lim},
  journal={The Lancet Neurology},
  year={2007},
  volume={6},
  pages={981-993}
}
Atrial fibrillation (AF) is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Anticoagulant therapy reduces the risk of stroke, and the greatest benefit is seen in patients at highest absolute risk. Aspirin is a less effective alternative, and any benefit of aspirin might be due to its favourable effects on arterial thrombosis caused by vascular disease. However, anticoagulant therapy remains underused, particularly… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 98 CITATIONS, ESTIMATED 38% COVERAGE

Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.

  • Journal of cardiovascular pharmacology and therapeutics
  • 2016
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Prevention Strategies for Cardioembolic Stroke: Present and Future Perspectives

VIEW 7 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Should HAS-BLED scoring be revised for better risk estimation in patients with intracerebral hemorrhage?

  • Expert review of cardiovascular therapy
  • 2014
VIEW 3 EXCERPTS
CITES METHODS, RESULTS & BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2008
2019

CITATION STATISTICS

  • 7 Highly Influenced Citations